Direct-to-Patient Survey Results Summary

Health Care, Innovation, Supply Chain

During the 2022 GCSG US conference in San Antonio, 65 attendees participated in our Direct-to-Patient (DtP) survey. While 2/3rd’s of the respondents represented pharmaceutical companies / sponsors, there is also a strong mix of input from service providers. Over 50% of participants also had experience with DtP. Though a need for technology improvements was noted, our industry‚Äôs adoption of patient centric services like DTP continues to boost the growth of decentralized trials.

Review the results!

Related Education Resources.

All Resources

Envisioning the Future of Clinical Supply Chains in the Next 10 Years

Topic: Supply Chain

Executive Summary


2019 European Knowledge Forum: Presentation and Workshop Slides

Topics: Communication, Conference, Personal Development, Pharma Industry



Brexit & the future landscape for clinical trial supplies in the UK and Europe

Topics: Pharma Industry, Regulatory, Supply Chain

Position Paper


Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.